Richard Thomas Williams is CHIEF MEDICAL OFFICER of Kinnate Biopharma Inc.. Currently has a direct ownership of 67,588 shares of KNTE, which is worth approximately $0. The most recent transaction as insider was on Mar 01, 2024, when has been sold 558 shares (Common Stock) at a price of $2.59 per share, resulting in proceeds of $1,445. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.6K
0% 3M change
1.6% 12M change
Total Value Held $0

Richard Thomas Williams Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2024
SELL
Payment of exercise price or tax liability
$1,445 $2.59 p/Share
558 Reduced 0.82%
67,588 Common Stock
Dec 01 2023
SELL
Payment of exercise price or tax liability
$1,217 $2.25 p/Share
541 Reduced 0.79%
68,146 Common Stock
Sep 01 2023
SELL
Payment of exercise price or tax liability
$1,271 $2.35 p/Share
541 Reduced 0.78%
68,687 Common Stock
Jun 01 2023
SELL
Payment of exercise price or tax liability
$2,326 $4.3 p/Share
541 Reduced 0.78%
69,228 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$3,323 $5.21 p/Share
638 Reduced 0.94%
67,295 Common Stock
Dec 01 2022
SELL
Payment of exercise price or tax liability
$4,192 $7.75 p/Share
541 Reduced 0.79%
67,933 Common Stock
Sep 01 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 26.75%
68,474 Common Stock
Mar 14 2022
BUY
Open market or private purchase
$209,250 $8.37 p/Share
25,000 Added 37.13%
42,333 Common Stock
Mar 11 2022
BUY
Open market or private purchase
$129,600 $8.64 p/Share
15,000 Added 46.39%
17,333 Common Stock
RTW

Richard Thomas Williams

CHIEF MEDICAL OFFICER
San Francisco, CA

Track Institutional and Insider Activities on KNTE

Follow Kinnate Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNTE shares.

Notify only if

Insider Trading

Get notified when an Kinnate Biopharma Inc. insider buys or sells KNTE shares.

Notify only if

News

Receive news related to Kinnate Biopharma Inc.

Track Activities on KNTE